《新股表現》瑞麗醫美(02135.HK)暗盤高開25%報0.5元
根據輝立交易平台顯示,下周一(28日)掛牌的瑞麗醫美(02135.HK)暗盤高開25%報0.5元,高低暫見0.56元/0.41元,現造0.475元,較上市價0.4元,高近19%,成交1.35億股。
瑞麗醫美是一間位於浙江省領先醫療美容服務提供商,服務包括美容外科服務和對面部或身體多個部位進行美容外科診療、微創美容及皮膚美容服務。
瑞麗是次來港上市共發售3.425億股,其中10%公開發售獲385倍超購,已重啟回撥機制佔比增至50%,認購一手中籤率僅3%;股份以招股範圍(0.3-0.4元)上限定價,料集資淨額約7,040萬元,主要用作翻新所有現有醫療美容機構並擴張杭州瑞麗、瑞麗天鴿及蕪湖瑞麗、為上海新建醫療美容機構資本支出及初始營運成本提供資金、用於浙江省醫療美容機構潛在戰略收購、購買醫療美容服務設備及醫療消耗品等。上市獨家保薦人創陞融資。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.